DLD. S. Luzhanskiy

D. S. Luzhanskiy

*This is an algorithmically generated author record based on publicly available information.

D. S. Luzhanskiy has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Endovascular embolization in the surgical treatment of renal angiomyolipoma

    by D. S. Luzhanskiy, I. A. . Aboyan, S. P. Semitko, Yа. V. Kulikovskikh, S. M. Pakus, T. Yu. Luneva, S. V. Ten, Д. С. Лужанский, И. А. Абоян, С. П. Семитко, et al.

    Introduction. Angiomyolipoma (AML) is the most common benign renal tumor. Selective arterial embolization of AML-feeding vessels is currently regarded as an effective organ-preserving treatment. However, the absence of unified criteria for predicting procedural success limits its widespread adoption. Objective. To evaluate the outcomes of endovascular embolization of renal AML according to tumor angioarchitectonic type. Materials & methods. This retrospective study included 30 patients with renal AML who underwent endovascular embolization between 2021 and 2024. Based on angiographic findings, all AMLs were classified into three types according to their vascular supply: type I (poor vascularization), type II (up to two major feeding arteries), and type III (multiple feeding arteries). Embolization was performed in patients with type II and III vascular patterns. Technical success of embolization, as well as changes in tumor size and volume at 6 and 12 months, were assessed. Results. The distribution of AMLs by vascular type was as follows: type I in 5 (17%) patients, type II in 16 (53%), and type III in 9 (30%). Embolization was technically not feasible in type I. Overall embolization success was achieved in 88% of cases (22 patients). Technical success was 100% for type II (16/16) versus 66.7% for type III (6/9). Statistical analysis demonstrated that the probability of successful embolization was 3.67 times higher for type II compared with type III (OR 3.67; 95% CI 1.85–7.26; p = 0.014). In all cases of successful embolization, a significant reduction in AML size and volume was observed during long-term follow-up. Conclusion. Selective embolization is an effective treatment for renal AML, achieving substantial tumor shrinkage. The proposed classification of AML vascular types is a clinically useful tool that allows stratification of patients by likelihood of technical success at the diagnostic angiography stage. The best embolization outcomes were observed in patients with type II angioarchitecture.

  • Open Access

    Intravascular ultrasound-guided renal artery stenting without the use of radiocontrast agents

    by I. A. Aboyan, Y. V. Kulikovskikh, N. V. Kalaitanova, R. H. Mkrtchyan, D. S. Luzhanskyi, D. V. Lavnik, D. S. Strokov, L. G. Oganesyan, M. Z. Gasanov, И. А. Абоян, et al.

    Aim . To analyze immediate and in-hospital outcomes of intravascular ultrasound (IVUS)-guided renal artery (RA) stenting without the use of radiocontrast agents in patients with chronic kidney disease (CKD) and renovascular hypertension. Material and methods . This prospective single-center study included 26 patients with CKD stage C3a-C5 and hemodynamically significant RA stenosis based on triplex ultrasound imaging. The patient age (median [min-max]) was 63 [48-76] years; 61,5% were women. Before the procedure, the median glomerular filtration rate (GFR) was 24 [1447] ml/min/1,73 m2, and creatinine — 287 [184-390] μmol/L. A total of 96,2% of patients had refractory hypertension, and 3,8% had a high renal dysfunction rate. All stages of the intervention were performed entirely under IVUS guidance. Technical success of the procedure, perioperative complications, and the incidence of any major adverse events during the hospital stay were assessed. Systolic blood pressure, serum creatinine, and eGFR were analyzed at discharge. Results. In two patients, IVUS revealed hemodynamically insignificant RA stenosis, therefore, stenting was not performed. The technical success of stenting was 100%. In 23 patients, the procedure was performed entirely without the use of a radiocontrast agent. In one patient, due to the specific RA involvement, ultra-low contrast administration was used. Following the intervention, the study group experienced a significant decrease in systolic blood pressure from 210 [140-260] to 130 [100-170] mm Hg (pConclusion . IVUS-guided RA stenting in patients with CKD stage C3a-C5 without the use of radiocontrast agents is technically feasible, effective, and safe. This technique can be considered a promising alternative to traditional approaches in carefully selected patients with contraindications to the use of radiocontrast agents.

  • Possibilities of CT perfusion in renal tumor cryoablation: а retrospective study

    by T. Yu. Luneva, D. S. Luzhanskiy, N. B. Volkonskaya, S. M. Pakus, I. A. Aboyan, V. V. Kapustin

    Introduction: Modern surgical treatment of localized renal cell carcinoma (RCC) is focused on organ-preserving methods, including ablative technologies (radiofrequency ablation, microwave ablation, and cryoablation). Despite the safety of ablative methods, the risk of incomplete ablation and local recurrence of kidney tumors remains, necessitating effective tools for early diagnosis. Perfusion computed tomography (CTP) offers the possibility of quantitative assessment of microcirculation in the ablation zone and detection of preserved vascularization. Objective: To analyze the potential of CTP for assessing the treatment effect of renal tumor cryoablation in the early and longterm postoperative periods. Materials and methods: The study analyzed data from standard multiphase computed tomography (Std-CT) and CTP of 40 patients with renal cell carcinoma aged 36–76 years before, on days 5–7, and 3 months after cryoablation. Based on CT results, 37 patients were determined to have complete ablation of the tumor node, and 3 patients had incomplete ablation. Arterial flow (AF), blood volume (BV), and vascular wall permeability (CL) in the tumor area were assessed. Results: In the group of patients with complete cryoablation (n=37), a statistically significant decrease in maximum CT density and perfusion parameters (BV, AF, CL) of the tumor was revealed on days 5–7 and 3 months after the procedure, reflecting ischemic changes and regression of tumor tissue. In patients with incomplete tumor ablation in the early postoperative period, areas of hyperperfusion in the cryodestruction zone were visualized, and a slight decrease in maximum densitometric values (HU) and perfusion parameters (BV, AF, CL) in the tumor node was noted. During follow-up at 3 months (n=2), an increase in density and a further rise in perfusion parameters in the residual tumor were detected, indicating preserved angiogenesis. Discussion: The results of this study are consistent with the works of other authors and confirm that CTP can serve as an additional technique for monitoring after renal tumor cryoablation. A decrease in CTP parameters in the cryoablation zone indicated complete destruction of the tumor node, while an increase in CTP values in local areas of the postoperative region indicated the preservation of viable tumor cells and served as an indicator of their activity, which was expressed in the presence of residual tumor. Conclusion: CT perfusion allows for assessing the treatment effect of cryoablation in the early postoperative period by evaluating changes in the quantitative characteristics of the microcirculatory bed in the solid component of the kidney tumor.

  • Open Access

    Renal angiomyolipomas. Possibilities of CT perfusion implementation for assessment of therapeutic effect of renal angiomyolipomas embolization. A review of literature and clinical observations

    by T. Yu. Luneva, D. S. Luzhanskiy, N. B. Volkonskaya, S. M. Pakus, I. A. Aboyan, V. V. Kapustin

    Purpose of the study: to analyze the data of domestic and foreign literature on the use of computed tomographic perfusion (CTP) in the diagnosis of kidney diseases, including patients with benign and malignant kidney tumors. To evaluate the prospects of using this technique to determine the effectiveness of various minimally invasive interventions (cryotherapy, various types of thermoablation, arterial embolization) for the treatment of patients with renal tumors, as well as for follow-up of patients in these groups. Material and methods. A search of scientific papers published in the electronic databases PubMed, Google Scholar, E-library using the key words “angiomyolipoma”, “kidney”, “transarterial embolization of tumors”, “CT-perfusion of the kidneys” was carried out. In the article the materials of 40 literature sources for the last 10 years, including 25 articles - for the last 5 years, devoted to the mentioned subject are considered. The authors present their own clinical cases demonstrating the CTP application usefulness to assess the therapeutic effect of renal angiomyolipomas (rAML) transarterial embolization (TAE). Results. The conducted literature review showed that renal CTP is a noninvasive technique that allows differential diagnostics between benign tumors (low-fat rAML and oncocytoma), as well as with malignant renal neoplasms, to reveal features of different histological variants of renal cell cancer. In addition, there are works devoted to the application of CTP in the evaluation of the efficacy of minimally invasive techniques such as cryoablation, TAE (in the treatment of renal cell cancer (RCC) and rAML, respectively), as well as target therapy for RCC. According to the preliminary results of our clinical cases, the main CTP parameters allowed to detail the structure of rAML (before and after TAE), blood flow features of its microcirculatory level and to detect recurrence on the basis of progressive growth of perfusion values with simultaneous reduction of tumor volume, which demonstrates the possibilities of using CTP as an additional monitoring technic after surgical treatment. Conclusion. Despite the availability of papers analyzing the use of CTP as a technique to assess renal tumor angiogenesis, many gaps remain in its use as a clinical potential in the evaluation of early and subsequent follow-up in the cases of renal tumors surgical treatment. To date, there is no evident and thoroughly validated imaging method for embolized tumors. There are no works on studying the possibilities of CTP in assessing the therapeutic effect of rAML embolization. The results of our own clinical cases allowed us to suggest that CTP can be used as an additional technique for monitoring rAML after surgical treatment such as TAE and detecting disease recurrence by assessing tumor neoangiogenesis.